Genomma Lab Internacional, S.A.B. de C.V. GNMLF
OTC PK
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.02% | 6.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.02% | 6.11% | |||
| Cost of Revenue | 12.16% | 2.81% | |||
| Gross Profit | -2.00% | 8.02% | |||
| SG&A Expenses | -2.34% | 11.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -78.50% | -193.04% | |||
| Total Operating Expenses | 3.98% | 7.34% | |||
| Operating Income | -0.84% | 1.45% | |||
| Income Before Tax | 31.72% | -16.04% | |||
| Income Tax Expenses | 15.89% | 8.43% | |||
| Earnings from Continuing Operations | 38.48% | -23.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 38.48% | -23.43% | |||
| EBIT | -0.84% | 1.45% | |||
| EBITDA | -0.75% | 1.39% | |||
| EPS Basic | -7.31% | -24.48% | |||
| Normalized Basic EPS | -11.79% | -17.37% | |||
| EPS Diluted | -7.31% | -24.48% | |||
| Normalized Diluted EPS | -11.79% | -17.37% | |||
| Average Basic Shares Outstanding | 49.29% | 1.61% | |||
| Average Diluted Shares Outstanding | 49.29% | 1.61% | |||
| Dividend Per Share | -- | 0.88% | |||
| Payout Ratio | -0.27% | 0.32% | |||